Selected research
Industry Research
OPO-containing Infant Formulas Industry Research Report 2026
Market perspective
The global OPO-containing Infant Formulas market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for OPO-containing Infant Formulas is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for OPO-containing Infant Formulas is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for OPO-containing Infant Formulas is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott and Brightdairy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global OPO-containing Infant Formulas market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OPO-containing Infant Formulas Market by Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita
OPO-containing Infant Formulas Segment by Type
Cow Milk Formula
Goat Milk Formula
OPO-containing Infant Formulas Segment by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
OPO-containing Infant Formulas Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OPO-containing Infant Formulas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OPO-containing Infant Formulas and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OPO-containing Infant Formulas.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OPO-containing Infant Formulas manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OPO-containing Infant Formulas by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OPO-containing Infant Formulas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cow Milk Formula
- Goat Milk Formula
Applications
- 0 - 6 Month
- 6 - 12 Month
- 12 - 36 Month
Companies covered
- BiosTime
- Nutriben
- Ausnutria
- HERDS
- Milupa
- Shanxi Yatai
- Beingmate
- Abbott
- Brightdairy
- Feihe
- Wyeth Nutrition
- Deloraine
- Yili
- Kabrita
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global OPO-containing Infant Formulas Market Size (2021-2032)
- 2.2.2 Global OPO-containing Infant Formulas Sales (2021-2032)
- 2.2.3 Global OPO-containing Infant Formulas Market Average Price (2021-2032)
- 2.3 OPO-containing Infant Formulas by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cow Milk Formula
- 2.3.3 Goat Milk Formula
- 2.4 OPO-containing Infant Formulas by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 0 - 6 Month
- 2.4.3 6 - 12 Month
- 2.4.4 12 - 36 Month
3 Market Competitive Landscape by Manufacturers
- 3.1 Global OPO-containing Infant Formulas Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global OPO-containing Infant Formulas Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global OPO-containing Infant Formulas Revenue of Manufacturers (2021-2026)
- 3.4 Global OPO-containing Infant Formulas Average Price by Manufacturers (2021-2026)
- 3.5 Global OPO-containing Infant Formulas Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of OPO-containing Infant Formulas, Product Type & Application
- 3.8 Global Manufacturers of OPO-containing Infant Formulas, Established Date
- 3.9 Global OPO-containing Infant Formulas Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BiosTime
- 4.1.1 BiosTime Company Information
- 4.1.2 BiosTime Business Overview
- 4.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BiosTime OPO-containing Infant Formulas Product Portfolio
- 4.1.5 BiosTime Recent Developments
- 4.2 Nutriben
- 4.2.1 Nutriben Company Information
- 4.2.2 Nutriben Business Overview
- 4.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nutriben OPO-containing Infant Formulas Product Portfolio
- 4.2.5 Nutriben Recent Developments
- 4.3 Ausnutria
- 4.3.1 Ausnutria Company Information
- 4.3.2 Ausnutria Business Overview
- 4.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ausnutria OPO-containing Infant Formulas Product Portfolio
- 4.3.5 Ausnutria Recent Developments
- 4.4 HERDS
- 4.4.1 HERDS Company Information
- 4.4.2 HERDS Business Overview
- 4.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HERDS OPO-containing Infant Formulas Product Portfolio
- 4.4.5 HERDS Recent Developments
- 4.5 Milupa
- 4.5.1 Milupa Company Information
- 4.5.2 Milupa Business Overview
- 4.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Milupa OPO-containing Infant Formulas Product Portfolio
- 4.5.5 Milupa Recent Developments
- 4.6 Shanxi Yatai
- 4.6.1 Shanxi Yatai Company Information
- 4.6.2 Shanxi Yatai Business Overview
- 4.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Portfolio
- 4.6.5 Shanxi Yatai Recent Developments
- 4.7 Beingmate
- 4.7.1 Beingmate Company Information
- 4.7.2 Beingmate Business Overview
- 4.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beingmate OPO-containing Infant Formulas Product Portfolio
- 4.7.5 Beingmate Recent Developments
- 4.8 Abbott
- 4.8.1 Abbott Company Information
- 4.8.2 Abbott Business Overview
- 4.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Abbott OPO-containing Infant Formulas Product Portfolio
- 4.8.5 Abbott Recent Developments
- 4.9 Brightdairy
- 4.9.1 Brightdairy Company Information
- 4.9.2 Brightdairy Business Overview
- 4.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Brightdairy OPO-containing Infant Formulas Product Portfolio
- 4.9.5 Brightdairy Recent Developments
- 4.10 Feihe
- 4.10.1 Feihe Company Information
- 4.10.2 Feihe Business Overview
- 4.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Feihe OPO-containing Infant Formulas Product Portfolio
- 4.10.5 Feihe Recent Developments
- 4.11 Wyeth Nutrition
- 4.11.1 Wyeth Nutrition Company Information
- 4.11.2 Wyeth Nutrition Business Overview
- 4.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Portfolio
- 4.11.5 Wyeth Nutrition Recent Developments
- 4.12 Deloraine
- 4.12.1 Deloraine Company Information
- 4.12.2 Deloraine Business Overview
- 4.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Deloraine OPO-containing Infant Formulas Product Portfolio
- 4.12.5 Deloraine Recent Developments
- 4.13 Yili
- 4.13.1 Yili Company Information
- 4.13.2 Yili Business Overview
- 4.13.3 Yili OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Yili OPO-containing Infant Formulas Product Portfolio
- 4.13.5 Yili Recent Developments
- 4.14 Kabrita
- 4.14.1 Kabrita Company Information
- 4.14.2 Kabrita Business Overview
- 4.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Kabrita OPO-containing Infant Formulas Product Portfolio
- 4.14.5 Kabrita Recent Developments
5 Global OPO-containing Infant Formulas Market Scenario by Region
- 5.1 Global OPO-containing Infant Formulas Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global OPO-containing Infant Formulas Sales by Region: 2021-2032
- 5.2.1 Global OPO-containing Infant Formulas Sales by Region: 2021-2026
- 5.2.2 Global OPO-containing Infant Formulas Sales by Region: 2027-2032
- 5.3 Global OPO-containing Infant Formulas Revenue by Region: 2021-2032
- 5.3.1 Global OPO-containing Infant Formulas Revenue by Region: 2021-2026
- 5.3.2 Global OPO-containing Infant Formulas Revenue by Region: 2027-2032
- 5.4 North America OPO-containing Infant Formulas Market Facts & Figures by Country
- 5.4.1 North America OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America OPO-containing Infant Formulas Sales by Country (2021-2032)
- 5.4.3 North America OPO-containing Infant Formulas Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe OPO-containing Infant Formulas Market Facts & Figures by Country
- 5.5.1 Europe OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe OPO-containing Infant Formulas Sales by Country (2021-2032)
- 5.5.3 Europe OPO-containing Infant Formulas Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific OPO-containing Infant Formulas Market Facts & Figures by Country
- 5.6.1 Asia Pacific OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific OPO-containing Infant Formulas Sales by Country (2021-2032)
- 5.6.3 Asia Pacific OPO-containing Infant Formulas Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America OPO-containing Infant Formulas Market Facts & Figures by Country
- 5.7.1 South America OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America OPO-containing Infant Formulas Sales by Country (2021-2032)
- 5.7.3 South America OPO-containing Infant Formulas Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa OPO-containing Infant Formulas Market Facts & Figures by Country
- 5.8.1 Middle East and Africa OPO-containing Infant Formulas Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa OPO-containing Infant Formulas Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa OPO-containing Infant Formulas Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global OPO-containing Infant Formulas Sales by Type (2021-2032)
- 6.1.1 Global OPO-containing Infant Formulas Sales by Type (2021-2032) & (k units)
- 6.1.2 Global OPO-containing Infant Formulas Sales Market Share by Type (2021-2032)
- 6.2 Global OPO-containing Infant Formulas Revenue by Type (2021-2032)
- 6.2.1 Global OPO-containing Infant Formulas Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global OPO-containing Infant Formulas Revenue Market Share by Type (2021-2032)
- 6.3 Global OPO-containing Infant Formulas Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global OPO-containing Infant Formulas Sales by Application (2021-2032)
- 7.1.1 Global OPO-containing Infant Formulas Sales by Application (2021-2032) & (k units)
- 7.1.2 Global OPO-containing Infant Formulas Sales Market Share by Application (2021-2032)
- 7.2 Global OPO-containing Infant Formulas Revenue by Application (2021-2032)
- 7.2.1 Global OPO-containing Infant Formulas Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global OPO-containing Infant Formulas Revenue Market Share by Application (2021-2032)
- 7.3 Global OPO-containing Infant Formulas Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 OPO-containing Infant Formulas Value Chain Analysis
- 8.1.1 OPO-containing Infant Formulas Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 OPO-containing Infant Formulas Production Mode & Process
- 8.2 OPO-containing Infant Formulas Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 OPO-containing Infant Formulas Distributors
- 8.2.3 OPO-containing Infant Formulas Customers
9 Global OPO-containing Infant Formulas Analyzing Market Dynamics
- 9.1 OPO-containing Infant Formulas Industry Trends
- 9.2 OPO-containing Infant Formulas Industry Drivers
- 9.3 OPO-containing Infant Formulas Industry Opportunities and Challenges
- 9.4 OPO-containing Infant Formulas Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst